9th Annual COPD: Novel Therapeutics and Management Strategies 2017 is a conference dedicated to the core issues and the alternatives to accelerate treatment development/.
9th Annual COPD: Novel Therapeutics and Management Strategies 2017 covers topics such as:
- COPD and comorbidities
- Formulation developments and the manufacturing of dry powder inhalation products
- "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
- The challenges in clinical trial designs and in drug development
- Recent advances made in COPD biomarkers
9th Annual COPD: Novel Therapeutics and Management Strategies 2017 brings together senior attendees with responsibilities in:
- Respiratory Pharmacology
- Respiratory Physiology & Medicine
- Inflammatory Disease
- Medical Affairs
- Pulmonary Disease
- Respiratory, Inflammation and Autoimmunity
- Immunology
- Respiratory Therapeutics
- In-Vitro Biology
- Medical & Inhalation Devices
- Inflammation Discovery
- Biomarker
- Clinical Pharmacology
- Preclinical R&D
- Clinical Science
- Clinical Trials
- Global Data Informatics
- Discovery
- Brand Manager
- Business Development
- Respiratory Licensing & Regulation
- Commercial